Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy

Abstract Background Studies regarding the impact of (neuro)inflammation and inflammatory response following repetitive, intrathecally administered antisense oligonucleotides (ASO) in 5q-associated spinal muscular atrophy (SMA) are sparse. Increased risk of hydrocephalus in untreated SMA patients and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Maren Freigang, Petra Steinacker, Claudia Diana Wurster, Olivia Schreiber-Katz, Alma Osmanovic, Susanne Petri, Jan Christoph Koch, Kevin Rostásy, Björn Falkenburger, Albert Christian Ludolph, Markus Otto, Andreas Hermann, René Günther
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-07-01
coleção:	Orphanet Journal of Rare Diseases
Assuntos:	SMA Chitotriosidase 1 Biomarker Nusinersen ASO
Acesso em linha:	https://doi.org/10.1186/s13023-021-01961-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!